erlotinib "stada" 25 mg filmovertrukne tabletter
stada arzneimittel ag - erlotinibhydrochlorid - filmovertrukne tabletter - 25 mg
trica 20 mg/ml injektionsvæske, suspension
riemser pharma gmbh - triamcinolonhexacetonid - injektionsvæske, suspension - 20 mg/ml
triamcinolonhexacetonid "2care4" 20 mg/ml injektionsvæske, suspension
2care4 aps - triamcinolonhexacetonid - injektionsvæske, suspension - 20 mg/ml
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
mirtazapin "bluefish" 15 mg smeltetabletter
bluefish pharmaceuticals ab - mirtazapin - smeltetabletter - 15 mg
mirtazapin "bluefish" 30 mg smeltetabletter
bluefish pharmaceuticals ab - mirtazapin - smeltetabletter - 30 mg
mirtazapin "bluefish" 45 mg smeltetabletter
bluefish pharmaceuticals ab - mirtazapin - smeltetabletter - 45 mg
mirtazapin "stada" 15 mg smeltetabletter
stada arzneimittel ag - mirtazapin - smeltetabletter - 15 mg
mirtazapin "stada" 30 mg smeltetabletter
stada arzneimittel ag - mirtazapin - smeltetabletter - 30 mg
mirtazapin "stada" 45 mg smeltetabletter
stada arzneimittel ag - mirtazapin - smeltetabletter - 45 mg